120 SUNDAY • MAY 15 102 Toll-Like Receptor Signaling in Human Lung Pericytes/J.P. Higuero, C.L. Wilson, L.M. Felton, S.E. Stephenson, C.F. Hung, W.A. Altemeier, J.E. Baatz, L.M. Schnapp, Charleston, SC, p.A2641 103 The RIG-I-Like Receptor Pathway Is Protective During Sterile Acute Lung Injury/M.P. Mohning, A.L. McCubbrey, K.J. Mould, P.M. Henson, W. Janssen, Aurora, CO, p.A2642 104 Toll-Like Receptor 5 Modulates MyD88-Dependent Toll-Like Receptor 4 Signaling/C.G. Johnson, J. Sciurba, A. Rice, J. Aloor, J. Cyphert, K. Bulek, X. Li, M.B. Fessler, S. Garantziotis, Research Triangle Park, NC, p.A2643 105 ApoA-I Binding Protein Attenuates Murine ARDS/B.T. Suratt, E. Burg, N. Ubags, S.-H. Choi, L. Fang, Y. Miller, Burlington, VT, p.A2644 106 Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury/R. Vittal, A.J. Fisher, E.L. Thompson, E.A. Mickler, M.R. Vasko, D.S. Wilkes, H. Gu, Ann Arbor, MI, p.A2645 107 Modulation of TLR3-Stimulated Release of IL-26 by IL-17A and IL-22 in Bronchial Epithelial Cells/K.F. Che, L. Palmberg, A. Linden, Stockholm, Sweden, p.A2646 108 Plasminogen Activator Inhibitor-1 (PAI-1) Plays a Critical Role in Alcohol-Enhanced Acute Lung Injury/L. Poole, V. Massey, E. Torres-Gonzalez, D. Siow, N. Warner, J. Luyendyk, J.D. Ritzenthaler, J. Roman, G. Arteel, Louisville, KY, p.A2647 109 Transient Receptor Potential Vanilloid Antagonism Alleviates the Propagation of Lung Injury/M. Cereda, Y. Xin, S. Kadlecek, J. Zeng, A. Rodriguez, H. Staroba, N. Meeder, Q. Bey, H. Profka, S. Siddiqui, M. Pourfathi, H. Hamedani, R.R. Rizi, Philadelphia, PA, p.A2648 110 Targeting Glutamine Metabolism as a Novel Means to Prevent LPS-Induced Acute Lung Injury/C.L. Vigeland, Y. Chan-Li, S.L. Collins, A.H. Hughes, M.-H. Oh, J.D. Powell, M.R. Horton, Baltimore, MD, p.A2649 111 Orchestrating Role of Apoptosis Inhibitor of Macrophage (AIM) in Resolution of Acute Lung Injury in Mice/H. Kimura, M. Suzuki, S. Konno, T. Miyazaki, H. Shindou, M. Nishimura, Sapporo, Japan, p.A2650 112 Uncoupled Inducible Nitric Oxide Synthase Influences Macrophage Polarization in Acute Lung Injury/T. Golden, M. Crabtree, K. Channon, A.J. Gow, Piscataway, NJ, p.A2651 113 1,5-Anhydro-D-Fructose, a Monosaccharide from Glycogen/Starch, Ameliorates Bleomycin-Induced Lung Injury by Inhibiting Inflammasome Activation/S. Noma, T. Saitoh, K.-I. Kawahara, Y. Ito, H. Inoue, I. Maruyama, Kamogawa City, Japan, p.A2652 114 Deficiency of a7 Nicotinic Acetylcholine Receptor Lessens Bleomycin-Induced Lung Injury and Fibrosis/X. Su, P. Sun, M. Pan, C. Zhao, L. Li, Shanghai, China, p.A2653 115 Heme Oxygenase-1 Regulates ROS-ERK1/2 Signaling in Silica-Induced Lung Injury/K. Nakashima, T. Sato, Y. Shibata, R. Ushio, M. Ikeda, H. Watanabe, K. Nagai, K. Tashiro, H. Nagakura, N. Horita, M. Yamamoto, M. Shinkai, M. Kudo, T. Kaneko, Yokohama, Japan, p.A2654 116 Immune Exhaustion and IL-6/STAT3 Activation in IPF Lymphocytes/A. Young, G. Shaginurova, J.A. Kropski, T.S. Blackwell, W. Drake, Nashville, TN, p.A2655 117 The EC-SOD R213G Polymorphism Enhances Recovery of Bleomycin-Induced Airway Inflammation Mitigating Subsequent Fibrosis and Pulmonary Hypertension/G.C. Mouradian, R. Gaurav, J. Maltzahn, J. Varasteh, B.C. Hartman, R.P. Bowler, E. Grayck, Aurora, CO, p.A2656 118 Circulating Fibrocytes as Biomarkers of Outcome in Acute Respiratory Distress Syndrome/A. Alrbiaan, M. Burdick, A. Kadl, K.B. Enfield, B. Mehrad, Charlottesville, VA, p.A2657 119 In Immature Mice, Hyperoxia-Activated CLEC9A+, CD103+ Dendritic Cells Are Sufficient to Confer Exaggerated T Cell Activation and Type 1 Inflammation/T. Cui, B. Maheshwer, A.P. Popova, Ann Arbor, MI, p.A2658 120 A Genome-Wide Association Study Identifies Genetic Variation in MBP that Is Associated with Ventilator-Free Days in Patients with ARDS in the iSPAAR Consortium/I. Barnett, C.S. Calfee, M. Matthay, N.J. Meyer, C. Mikacenic, G. O’Keefe, H. Hakonarson, A.J. Sandford, M. Obeidat, D.S. Postma, D.C. Nickle, Y. Bosse, G.P. Jarvik, K. Walley, J. Russell, X. Lin, D.C. Christiani, M.M. Wurfel, Boston, MA, p.A2659 121 Airway Inflammation at Birth and Lung Function at School Age in Preterm Neonates: A Pilot Study/M. Slaats, M. Al-Nejar, N. Everaars, E. Wouters, L. Mahieu, E. Oostveen, J. De Dooy, W. De Backer, S. Verhulst, Edegem, Belgium, p.A2660 122 Regulation of Pseudomonas Aeruginosa Exoprotease and Elastase Activity by Thrombospondin-1/J. Zupetic, Y. Qu, T.F. Olonisakin, M. Hulver, Z. Xiong, J. Bomberger, P. Thibodeau, P. Ray, J.S. Lee, Pittsburgh, PA, p.A2661 123 Circulating Thrombogenic Endothelial Cell-Derived Microparticles Are Present in Patients with Systemic Sclerosis/M.J. Scott, S. Osher, M. Hinchcliff, J.E. Dematte, I. Weiss, M. Cuttica, L. Morales-Nebreda, J. Varga, D. Vaughan, H.C. Kwaan, G.S. Budinger, G.M. Mutlu, Chicago, IL, p.A2662 124 G-CSF and IL-6 Are Required for Early Post Burn Neutrophilia and Increased Lung Myeloperoxidase Activity/J.C. Gardner, J.G. Noel, L. Pitstick, N.M. Nikolaidis, F.X. McCormack, Cincinnati, OH, p.A2663 125 Genome-Wide Expression Profiling of Acute Respiratory Distress Syndrome (ARDS)/P. Tejera, R. Zhang, Y. Wei, Z. Zhu, Z. Wang, L. Su, D.C. Christiani, Boston, MA, p.A2664 A102 POSTER DISCUSSION SESSION HIGHLIGHTS IN PATIENT-CENTERED RESEARCH: METHODS AND OUTCOMES 2:15 p.m. - 4:15 p.m. MOSCONE CENTER Room 309 (South Building, Esplanade Level) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 ATS 2016 • San Francisco
SUNDAY • MAY 15 121 Chairing: M.K. Gould, MD, MS, Pasadena, CA S.J. Bartlett, PhD, Montreal, Canada R.A. Mularski, MD, MSHS, Portland, OR 301 The PROMPT Study: Participatory Research in Ottawa: Management and Point-of-Care of Tobacco - A Community-Based Participatory Action Research Project/S. Pakhale, T. Kaur, T. Rose, K. Florence, S. LeBlanc, W. Muckle, R. Boyd, D. Pettey, J. Haddad, A. Pipe, R. Reid, M. Tyndall, Ottawa, Canada, p.A2665 302 Patients as Research Partners in Chronic Respiratory Disease (CRD) Research: Priorities, Challenges and Suggestions Made by Patients and Caregivers/I. Poureslami, S. Pakhale, K. Lavoie, T. To, L.-P. Boulet, S. Gupta, S. Aaron, M. Fitzgerald, Vancouver, Canada, p.A2666 303 Using Exploratory Study to Inform the Development of a Peer Supported Pulmonary Rehabilitation <strong>Program</strong>: Directions for Further Research/I. Poureslami, J. Shum, M.J. Fitzgerald, Vancouver, Canada, p.A2667 304 Driving Investment in Asthma Research in Europe: Priorities to Prevent, Cure and Manage Asthma More Effectively/S.C. Masefield, P. Powell, E.J. Kennington, J.L. Edwards, K. Cowan, L. Metcalf, S. Walker, Sheffield, United Kingdom, p.A2668 305 What Asthma Self-Management Tools and Systems Should Have Higher Priority in Future Research: A Delphi Exercise from the EU/L. Garcia-Marcos, J.L. Edwards, E.J. Kennington, S. Walker, Murcia, Spain, p.A2669 306 Transforming Asthma Outcomes Through Co-Ordinated National and Regional Health Initiatives: Review and Policy Recommendations/G. De Carlo, J. De Vocht, J.L. Edwards, E.J. Kennington, S. Walker, Brussels, Belgium, p.A2670 307 Asking Patients, Caregivers, and Clinicians for Input When Designing the Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Trial/J.A. Krishnan, J.W. Walsh, H.A. Gussin, N.E. Bracken, E. Malanga, J. Sullivan, R. Albert, K. Erwin, J. Holbrook, S.I. Rennard, E. Sugar, R.A. Wise, Chicago, IL, p.A2671 308 First Year Registration Data for Enrollees in the COPD Foundation Patient Powered Research Network/R.A. Mularski, J.W. Walsh, D.M. Mannino, C. Pasquale, S.E. Gillespie, P. Crawford, E. Malanga, M.A. McBurnie, Portland, OR, p.A2672 309 Alpha-1 Clinical Demographics and Outcomes: Data from the Alpha-1 Therapy, Evaluation and Research (AL1TER) Patient Registry <strong>Program</strong>/S. Kearns, L. Kristofek, B. Bolgar, D. Schmechel, Denver, CO, p.A2673 310 Characteristics of COPD Patients Who Agree to Participate in a Pragmatic Trial of Physical Activity Coaching Compared to Non-Participants/L. Maddock, E. Rippberger, J. Wang, J.S. Lee, K.J. Coleman, S.A. Desai, V.S. Fan, M.K. Gould, M.L. Moy, W.J. Towner, A. Xiang, H.Q. Nguyen, Pasadena, CA, p.A2674 311 Predictors of Drop-Out from a Longitudinal Biobehavioral Research Study/E. Cuenco, V. Carrieri-Kohlman, R.T. Disler, D. Donesky, Benicia, CA, p.A2675 312 Structured Reporting Forms (SRF) and a Pilot Study in Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF)/D. Szapiro, L. Bidaut, A. Gangi, T. Hartley, D.J. Dhasmana, Kirkcaldy, United Kingdom, p.A2676 313 Expanding ICU Stakeholder Participation in the Delphi Method: The Critical Care Aligned with Patient Goals Project/A.E. Turnbull, S.K. Sahetya, M.D. Hashem, D.M. Needham, Baltimore, MD, p.A2677 314 Care Practices and Health-Related Quality of Life for Ventilator-Assisted Individuals: A Cross-National Study/L.M. Hannan, H. Sahi, J. Road, C.F. McDonald, D.J. Berlowitz, M.E. Howard, Melbourne, Australia, p.A2678 315 Relative and Absolute Reliability and Other Properties of the Asthma Impact on Quality of Life Scale (A-IQOLS) and Flanagan QOLS: Results of the AQOLIS Test-Retest Study/S.R. Wilson, S.B. Knowles, M. Mulligan, A. Chausow, E. Ayala, R.A. Wise, M. Castro, Q. Huang, Palo Alto, CA, p.A2679 316 Efficacy of the Adherence Starts with Knowledge 12 (ASK-12) Questionnaire Japanese Version in Japanese Actual Clinical Setting/Y. Kimura, A. Aoki, H. Takeuchi, M. Kurokawa, M. Hayashi, T. Sakagami, T. Koya, T. Hasegawa, Niigata, Japan, p.A2680 317 Alexithymia Related to Control, Severity and Adherence in Asthmatic Patients: Pilot Study in Ecuador/I. Cherrez, F. Reyes, J.C. Calderon, P. Beltran, E. Calero, A. Cherrez, Guayaquil, Ecuador, p.A2681 318 The Relationship Between Disease Knowledge, Self-Efficacy and Adherence to Treatment in Adolescents with Cystic Fibrosis/J.M. Foster, N. Faint, J. Staton, S. Stick, A. Schultz, Sydney, Australia, p.A2682 319 Shared Decision Making Tool for Self-Management of Home Therapies for Patients with Cystic Fibrosis/M.H. Eckman, P.M. Joseph, E.J. Kopras, K. Montag-Leifling, M. Meyers, Cincinnati, OH, p.A2683 320 Association of Actual and Preferred Decision-Making Roles with Patient-Reported Satisfaction and Quality of Medical Care Among Patients with Pulmonary Nodules/D.R. Sullivan, S.E. Golden, L. Ganzini, R.S. Wiener, C.G. Slatore, Portland, OR, p.A2684 321 Even if I Don’t Remember I Feel Better: A Qualitative Study of Early Stage Non-Small Cell Lung Cancer Patients Undergoing Treatment/S.E. Golden, C. Thomas, C.G. Slatore, Portland, OR, p.A2685 322 Lung Nodules: Less Is Not More/C.T. Pantin, K. Hughes, M. Cheema, J. Corless, S. Iyer, Macclesfield, United Kingdom, p.A2686 323 Alcohol Misuse, Social Support, and Delays in Seeking Medical Care/M. Reisinger, M. Moss, B. Clark, Denver, CO, p.A2687 324 Perceptions of a Modified Mindfulness Training (MT) <strong>Program</strong> in Sarcoidosis/L.A. Saketkoo, J. Young, R. Adell, A.C. Karpinski, M. Walker, A.-M. Russell, New Orleans, LA, p.A2688 SUNDAY AFTERNOON ATS 2016 • San Francisco
- Page 1 and 2:
American Thoracic Society Internati
- Page 3:
TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7:
2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9:
4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11:
6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13:
8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15:
10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17:
12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19:
14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21:
16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23:
18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25:
20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27:
22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29:
24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31:
26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33:
28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35:
30 SUNDAY • MAY 15 • understand
- Page 36 and 37:
32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39:
34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41:
36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43:
38 SUNDAY • MAY 15 310 A Smartpho
- Page 44 and 45:
40 SUNDAY • MAY 15 103 Immunosupp
- Page 46 and 47:
42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49:
44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51:
46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53:
48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55:
50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57:
52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59:
54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61:
56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63:
58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65:
60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67:
62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69:
64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71:
66 SUNDAY • MAY 15 P91 Facilitato
- Page 72 and 73:
68 SUNDAY • MAY 15 P616 P617 P618
- Page 74 and 75: 70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77: 72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79: 74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81: 76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83: 78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85: 80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87: 82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89: 84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91: 86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93: 88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95: 90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97: 92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99: 94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101: 96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103: 98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105: 100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107: 102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109: 104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111: 106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113: 108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115: 110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117: 112 SUNDAY • MAY 15 clinician and
- Page 118 and 119: 114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121: 116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123: 118 SUNDAY • MAY 15 3:30 High Pre
- Page 126 and 127: 122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129: 124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131: 126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133: 128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135: 130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137: 132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139: 134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141: 136 MONDAY • MAY 16 Target Audien
- Page 142 and 143: 138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145: 140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147: 142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149: 144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151: 146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153: 148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155: 150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157: 152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159: 154 MONDAY • MAY 16 718 Health Re
- Page 160 and 161: 156 MONDAY • MAY 16 P152 Facilita
- Page 162 and 163: 158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165: 160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167: 162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169: 164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171: 166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173: 168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175:
170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177:
172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179:
174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181:
176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183:
178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185:
180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187:
182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189:
184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191:
186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193:
188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195:
190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197:
192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199:
194 MONDAY • MAY 16 P1455 P1456 P
- Page 200 and 201:
196 MONDAY • MAY 16 P1487 P1488 P
- Page 202 and 203:
198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205:
200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207:
202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209:
204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211:
206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213:
208 MONDAY • MAY 16 Objectives At
- Page 214 and 215:
210 MONDAY • MAY 16 encourage tra
- Page 216 and 217:
212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219:
214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221:
216 MONDAY • MAY 16 and a number
- Page 222 and 223:
218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225:
220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227:
222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229:
224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231:
226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233:
228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235:
230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237:
232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239:
234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241:
236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243:
238 TUESDAY • MAY 17 This session
- Page 244 and 245:
240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247:
242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249:
244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275:
270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277:
272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279:
274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281:
276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283:
278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285:
280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287:
282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289:
284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291:
286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293:
288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295:
290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297:
292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299:
294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301:
296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303:
298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305:
300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307:
302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309:
304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311:
306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313:
308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315:
310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317:
312 TUESDAY • MAY 17 • become a
- Page 318 and 319:
314 TUESDAY • MAY 17 The topics a
- Page 320 and 321:
316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323:
318 TUESDAY • MAY 17 C89 BASIC
- Page 324 and 325:
320 TUESDAY • MAY 17 3:20 Pediatr
- Page 326 and 327:
322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329:
324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331:
326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333:
328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335:
330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337:
332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339:
334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341:
336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343:
338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345:
340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347:
342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349:
344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351:
346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353:
348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355:
350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357:
352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359:
354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361:
356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363:
358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365:
360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367:
362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369:
364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371:
366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373:
368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375:
370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377:
372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379:
374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381:
376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383:
378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385:
380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387:
382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389:
384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391:
386 WEDNESDAY • MAY 18 P1036 P103
- Page 392 and 393:
388 WEDNESDAY • MAY 18 P1062 P106
- Page 394 and 395:
390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397:
392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399:
394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401:
396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403:
398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405:
400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407:
402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409:
404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411:
406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413:
408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415:
410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417:
412 WEDNESDAY • MAY 18 404 Interm
- Page 418:
Where today’s science meets tomor